Oncology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Talimogene laherparepvec"

Rresults from a pivotal phase 3 trial evaluating Talimogene Laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor ( GM- ...

The advent of new immunotherapies for the treatment of metastatic melanoma has resulted in various novel combination strategies. Because of their distinct modes of action, different immunotherapies ha ...

This is the first randomized trial testing the addition of an oncolytic virus to an immune checkpoint inhibitor for advanced melanoma. At the 3-year follow-up, the combination ( combo ) of Talimog ...